
Samsara Biocapital is seeking to raise $500 million for its new fund, according to an SEC filing. Based in Palo Alto, California, Samsara Biocapital invests in biotech innovation.
Source: SEC filing
Samsara Biocapital is seeking to raise $500 million for its new fund, according to an SEC filing.
Samsara Biocapital is seeking to raise $500 million for its new fund, according to an SEC filing. Based in Palo Alto, California, Samsara Biocapital invests in biotech innovation.
Source: SEC filing
Copyright PEI Media
Not for publication, email or dissemination